SCHEMBL17836918

SCHEMBL17836918

FC(=Cc1ccccc1)C(F)(F)F

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.45
TSHR P16473 1/20 0.45
AKR1C3 P42330 1/20 0.45
FBP1 P09467 3/20 0.41
AKR1C1 Q04828 1/20 0.39
ESR1 P03372 1/20 0.39
KDM1A O60341 1/20 0.38
RECQL P46063 1/20 0.38
CES1 P23141 1/20 0.38
HTT P42858 1/20 0.37
GLA P06280 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
PRMT1 Q99873 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17836916 1.00 ALDH1A1 (0.45) ALDH1A1TSHRAKR1C3FBP1AKR1C1
SCHEMBL19056954 0.81 TP53 (0.38) ALDH1A1ESR1LMNAMAPT
SCHEMBL19056955 0.81 TP53 (0.38) ALDH1A1ESR1LMNAMAPT
SCHEMBL9227437 0.79 ALDH1A1 (0.48) ALDH1A1TSHRAKR1C3FBP1AKR1C1
SCHEMBL9227444 0.79 ALDH1A1 (0.48) ALDH1A1TSHRAKR1C3FBP1AKR1C1
SCHEMBL453533 0.78 ALDH1A1 (0.41) ALDH1A1TSHRAKR1C3FBP1AKR1C1
SCHEMBL7031297 0.78 ALDH1A1 (0.41) ALDH1A1TSHRAKR1C3FBP1AKR1C1
SCHEMBL31464217 0.76 ALDH1A1 (0.40) ALDH1A1TSHRAKR1C3FBP1AKR1C1
SCHEMBL14518618 0.75 ALDH1A1 (0.54) ALDH1A1TSHRAKR1C3FBP1AKR1C1
SCHEMBL7633159 0.75 ALDH1A1 (0.54) ALDH1A1TSHRAKR1C3FBP1AKR1C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10421702-B2 Method for producing fluorine-containing olefin AGC Inc. (JP) 2019-09-24 US disclosed
CN-105517982-B The manufacturing method of Fluorine containing olefine AGC株式会社 2018-12-04 CN disclosed
US-20180086684-A1 METHOD FOR PRODUCING FLUORINE-CONTAINING OLEFIN ASAHI GLASS COMPANY, LIMITED (JP) 2018-03-29 US disclosed
US-9796647-B2 Method for producing fluorine-containing olefin ASAHI GLASS COMPANY, LIMITED (JP) 2017-10-24 US disclosed
US-20170101360-A1 METHOD FOR PRODUCING FLUORINE-CONTAINING OLEFIN ASAHI GLASS COMPANY, LIMITED (JP) 2017-04-13 US disclosed
US-9598335-B2 Method for producing fluorine-containing olefin ASAHI GLASS COMPANY, LIMITED (JP) 2017-03-21 US disclosed
EP-3042889-A1 METHOD FOR PRODUCING FLUORINE-CONTAINING OLEFIN Asahi Glass Company, Limited (JP) 2016-07-13 EP disclosed
EP-3042889-A1 METHOD FOR PRODUCING FLUORINE-CONTAINING OLEFIN Asahi Glass Company, Limited (JP) 2016-07-13 EP disclosed
US-20160176791-A1 METHOD FOR PRODUCING FLUORINE-CONTAINING OLEFIN ASAHI GLASS COMPANY, LIMITED (JP) 2016-06-23 US disclosed
CN-105517982-A Method for producing fluorine-containing olefin ASAHI GLASS CO LTD 2016-04-20 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180086684-A1 METHOD FOR PRODUCING FLUORINE-CONTAINING OLEFIN FOS, CYP2F1, CYP4F11 ALDH1A1 607/4885TSHR 1612/4885AKR1C3 900/4885
US-10421702-B2 Method for producing fluorine-containing olefin FOS, CYP2F1, CYP4F11 ALDH1A1 607/4885TSHR 1612/4885AKR1C3 900/4885
US-20170101360-A1 METHOD FOR PRODUCING FLUORINE-CONTAINING OLEFIN FOS, CYP2F1, CYP4F11 ALDH1A1 607/4885TSHR 1612/4885AKR1C3 900/4885
US-20160176791-A1 METHOD FOR PRODUCING FLUORINE-CONTAINING OLEFIN FOS, CYP2F1, CYP4F11 ALDH1A1 607/4885TSHR 1612/4885AKR1C3 900/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.